THE USE OF DRIED BLOOD SPOTS FOR MEASURING THE IMMUNITY AGAINST HBV

THE SIGNIFICANCE OF ANTIBODY DILUTION

Authors

  • Chijdem Ismailova, MSc National Centre of Infectious and Parasitic Diseases
  • Assistant Professor Elica Golkocheva-Markova,PhD National Centre of Infectious and Parasitic Diseases
  • TenchoTenev, MD National Centre of Infectious and Parasitic Diseases
  • Assistant Professor Stefka Krumova, PhD National Centre of Infectious and Parasitic Diseases

Keywords:

DBS, anti-HBs, HBV

Abstract

Background: Dried blood spots (DBS) have been used to study the prevalence of hepatitis B virus (HBV) infection in endemic areas and in high-risk groups. However, detection of HBV serological markers in DBS by ELISA assays has not yet been fully optimised. The aim of the present study is to evaluate the dilution level of anti-HBs when DBS cards are used as storage matrix implemented for ELISA.

Material and methods: Antibodies against hepatitis B surface antigen (anti-HBs) were detected by ELISA. The following specimens were examined: serum samples from 20 patients paired with 20 DBS; serum samples from 20 HBV-vaccinated healthcare workers paired with 20 dried serum spots (DSS); and four different dilutions of Immunovenin. Different elution protocols were used in order to study the problem with sample dilution.

Results: Specificity of 100% and sensitivity of 45% were established for DBS versus the “gold standard”. Dilution of the eluted DBS/DSS samples was established and in some cases the measured anti-HBs titre dropped under 10 mIU/ml. Correlation was not observed between the positive initial anti-HBs serum titres and the obtained values of DBS/DSS testing. Also, 20- to 50-fold dilutions were measured for eluted DSS samples when testing Immunovenin. Increasing of the eluted sample concentration raised DSS anti-HBs titre.

Conclusions: In order to resolve the problem of dilution, it is necessary to validate different elution protocols because the small amount of sample in DBS showed lower titres.

Author Biographies

Chijdem Ismailova, MSc, National Centre of Infectious and Parasitic Diseases

NRL of Hepatitis viruses

Assistant Professor Elica Golkocheva-Markova,PhD, National Centre of Infectious and Parasitic Diseases

NRL of Hepatitis viruses

TenchoTenev, MD, National Centre of Infectious and Parasitic Diseases

Head of NRL of Hepatitis viruses

Assistant Professor Stefka Krumova, PhD, National Centre of Infectious and Parasitic Diseases

Head of NRL of Measles, Mumps and Rubella

References

Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015; 386(10003):1546–1555.

European Centre for Disease Prevention and Control. Hepatitis B Surveillance in Europe – 2014. Stockholm: ECDC, 2016.

Kurchatova A, Vladimirova N, Minkova A, Kamenov G, Stoitsova S, Parmakova K. Acute infectious diseases in Bulgaria in 2017 (Key Epidemiological Indicators). https://www.ncipd.org/index.php?option=com_docman&view=list&slug=analysis-2017&Itemid=1127&lang=bg

Børresen ML, Koch A, Biggar RJ, Ladefoged K, Melbye M, Wohlfahrt J, Krause TG. Effectiveness of the targeted hepatitis B vaccination program in Greenland. Am J Public Health. 2012; 102(2):277-284.

Todorova TT, Tsankova G, Lodozova N. Hepatitis B infection in eastern regions of Bulgaria. J IMAB. 2016; 22(1):1033-1035.

Golkocheva-Markova E, Alexiev I, Teoharov P. Relation between hepatitis B surface antigen kinetic and viral replication in patients with resolved hepatitis B virus infection. Probl Infect Parasit Dis. 2013; 41(2):24-28.

Song JE, Kim DY. Diagnosis of hepatitis B. Ann Transl Med. 2016; 4(18):338.

World Health Organization. Hepatitis B: Serological and clinical patterns of acute or chronic HBV infections. WHO 2002. http://www.who.intemcdocuments/hepatitis/docs/whocdscsrlyo20022/disease/serological_clinical_pattern.html

Su TH, Chen PJ. Emerging hepatitis B virus infection in vaccinated populations: a rising concern? Emerg Microbes Infect. 2012; 1(9):e27.

Guthrie R, Susi A. A Simple Phenylalanine Method for Detecting Phenylketonuria in Large Populations of Newborn Infants. Pediatrics. 1963; 32:338-343.

Chace DH, De Jesús VR, Spitzer AR. Clinical chemistry and dried blood spots: increasing laboratory utilization by improved understanding of quantitative challenges. Bioanalysis. 2014; 6(21):2791-2794.

Smit PW, Elliott I, Peeling RW, Mabey D, Newton PN. An overview of the clinical use of filter paper in the diagnosis of tropical diseases. Am J Trop Med Hyg. 2014; 90(2):195-210.

Marques B, Brandão C, Silva E, Marques V, Villela-Nogueira C, Do ÓK, de Paula M, Lewis-Ximenez L, Lampe E, Villar L. Dried blood spot samples: Optimization of commercial EIAs for hepatitis C antibody detection and stability under different storage conditions. J Med Virol. 2012; 84:1600-1607.

Mössner BK, Staugaard B, Jensen J, Lillevang ST, Christensen PB, Holm DK. Dried blood spots, valid screening for viral hepatitis and human immunodeficiency virus in real-life. World J Gastroenterol. 2016; 22(33):7604-7612.

Krumova S, Golkocheva-Markova E, Pavlova A, Angelova S, Georgieva I, Genova-Kalou. P. Detection of measles and rubella antibodies in dried blood spots. Probl Infect Parasit Dis. 2018; 46(2):20-24.

Smit PW, Elliott I, Peeling RW, Mabey D, Newton PN. An overview of the clinical use of filter paper in the diagnosis of tropical diseases. Am J Trop Med Hyg. 2014; 90(2):195-210.

Ross RS, Stambouli O, Grüner N, Marcus U, Cai W, Zhang W, Zimmermann R, Roggendorf M. Detection of infections with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus by analyses of dried blood spots-performance characteristics of the ARCHITECT system and two commercial assays for nucleic acid amplification. Virol J. 2013; 10:72.

Lim MD. Dried Blood Spots for Global Health Diagnostics and Surveillance: Opportunities and Challenges. Am J Trop Med Hyg. 2018; 99(2):256-265.

Downloads

Published

2019-06-27

How to Cite

Ismailova, C., Golkocheva-Markova, E., Tenev, T., & Krumova, S. (2019). THE USE OF DRIED BLOOD SPOTS FOR MEASURING THE IMMUNITY AGAINST HBV: THE SIGNIFICANCE OF ANTIBODY DILUTION. PROBLEMS of Infectious and Parasitic Diseases, 47(1), 16-20. Retrieved from https://pipd.ncipd.org/index.php/pipd/article/view/47_1_3_USE_OF_DRIED_BLOOD_SPOTS_FOR_MEASURING_THE_IMMUNITY_AGAIN

Issue

Section

Articles

Most read articles by the same author(s)